Search

To investigate safety, early imaging response, and survival analysis of radioembolization for the treatment of intrahepatic cholangiocarcinoma using >=150 Gy MIRD (Medical Internal Radiation Dose). Imaging analysis with mRECIST found 12 (33.3%) complete responses, 21 (58.3%) partial responses, and 3 (8.3%) with stable disease. Patients with complete response had increased survival when compared to the patients with partial response and stable disease. [Extracted from the article]

Percutaneous tumor biopsy is recommended prior to percutaneous ablation of renal masses; however, reported complications of hemorrhage in up to 91% of cases in addition to probe crowding in small lesions may negatively affect mass visualization. From December 2018 to July 2019, 8 patients with solid renal masses (1.6 to 2.2 cm) per contrast-enhanced MRI or CT concerning for malignancy underwent single session CT-guided percutaneous cryoablation and subsequent biopsy of ablated tissue. [Extracted from the article]

To evaluate the pathologic findings in liver explants of patients with hepatocellular carcinoma (HCC) who received radiation segmentectomy. Patients were excluded if the treatment angiosome did not provide complete tumor coverage per mapping angiography or the target lesion could not be correlated with gross pathology. After 2 patients were excluded, a total of 32 patients and 34 tumors were analyzed. [Extracted from the article]